Clinical Trials Browser

Recurrence × siltuximab × Clear all

NCT01309412 2014-05-19

A Phase 1 Study of CNTO 328 (Siltuximab) in Relapsed or Refractory Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma, Recurrence

NCT01266811 2013-01-28

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma, Recurrence